Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.
Henry Ford Hospital, Detroit, MI.
E J
EJ
Tilchen
T
T
Fleming
G
G
Mills
N
N
Oishi
J D
JD
Bonnett
R B
RB
Natale
G
G
Harker
C A
CA
Coltman
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D001388:Aziridines / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use*; D016227:Benzoquinones; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy*
D001388:Aziridines; D001389:Azirines; D016227:Benzoquinones; C029108:diaziquone